These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

321 related items for PubMed ID: 14144353

  • 21. [THE PRODUCTION OF RESISTANCE AGAINST ISOLOGOUS TRANSPLANTS OF ULTRAVIOLET-INDUCED SARCOMA IN MICE].
    GRAFFI A, PASTERNAK G, HORN KH.
    Acta Biol Med Ger; 1964; 12():726-8. PubMed ID: 14242071
    [No Abstract] [Full Text] [Related]

  • 22. [THE BEHAVIOR OF CIRCULATING ANTIBODIES AND PROPERDIN FOLLOWING SENSITIZATION WITH HOMOLOGOUS TISSUE ANTIGENS].
    SCHEIFFARTH F, WARNATZ H, FRENGER W, HALFAR I, TYMPNER KD.
    Z Gesamte Exp Med; 1964 Feb 17; 138():81-91. PubMed ID: 14161934
    [No Abstract] [Full Text] [Related]

  • 23. ANTIGENICITY OF A CRUDE LIPOPOLYSACCHARIDE FRACTION OF THE METHYLCHOLANTHRENE-INDUCED TUMOR, WITH SPECIAL REFERENCE TO ISOLOGOUS IMMUNITY IN INBRED RATS.
    MATSUMOTO T.
    Gan; 1965 Feb 17; 56():1-11. PubMed ID: 14326031
    [No Abstract] [Full Text] [Related]

  • 24. RELATIONSHIP BETWEEN HUMORAL AND CELLULAR ISOANTIBODIES. I. INABILITY OF HUMORAL ISOANTIBODIES TO PREVENT THE CYTOTOXIC EFFECT OF IMMUNE LYMPHOCYTES.
    BRONDZ BD.
    Transplantation; 1965 May 17; 3():356-67. PubMed ID: 14285088
    [No Abstract] [Full Text] [Related]

  • 25. STUDIES ON SPECIFIC TRANSPLANTATION RESISTANCE TO POLYOMA-VIRUS-INDUCED TUMORS. IV. STABILITY OF THE POLYOMA CELL ANTIGEN.
    SJOEGREN HO.
    J Natl Cancer Inst; 1964 Mar 17; 32():661-6. PubMed ID: 14130678
    [No Abstract] [Full Text] [Related]

  • 26. Complete in vivo destruction of allografted sarcoma I cells by circulating antibodies.
    Kinsky R, Chouroulinkov I, Voisin GA.
    Transplantation; 1970 Nov 17; 10(5):450-1. PubMed ID: 5490529
    [No Abstract] [Full Text] [Related]

  • 27. ANTIGENS IN HUMAN MALIGNANT TISSUE AND DEVELOPMENT OF ANTISERUM IN HORSES.
    BLANEY DJ, ROTTE TC, SILER VE.
    Surg Gynecol Obstet; 1964 Feb 17; 118():341-6. PubMed ID: 14119116
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Serological responses of mice during active enhancement of tumour allografts.
    Mildenhall P, Nelson DS.
    Br J Exp Pathol; 1968 Apr 17; 49(2):170-8. PubMed ID: 5646469
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Studies on the mechanism of immunological enhancement of tumor homografts. III. Interaction between humoral isoantibodies and immune lymphoid cells.
    MOLLER G.
    J Natl Cancer Inst; 1963 Jun 17; 30():1205-26. PubMed ID: 13935882
    [No Abstract] [Full Text] [Related]

  • 35. DEMONSTRATION OF SYNGENEIC PREFERENCE IN VITRO.
    HELLSTROEM KE, HELLSTROEM I, HAUGHTON G.
    Nature; 1964 Nov 14; 204():661-4. PubMed ID: 14236283
    [No Abstract] [Full Text] [Related]

  • 36. THE BIOLOGY OF TISSUE TRANSPLANTATION.
    RUSSELL PS, MONACO AP.
    N Engl J Med; 1964 Sep 17; 271():610-5 CONTD. PubMed ID: 14172973
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. [IMMUNOLOGICAL STUDY OF AN ANTILEUKOCYTE HETERO-ANTISERUM].
    LUZZATI AL, GALLINARO P, BERNOCO D.
    Boll Ist Sieroter Milan; 1964 Sep 17; 43():77-88. PubMed ID: 14134477
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.